Evaluation of clinical spectrum and risk factors in young stroke patients at a tertiary level hospital, Patna, Bihar
Keywords:
stroke, young patient, risk factorAbstract
Background: Stroke is the most frequent neurological disorder that results in long-term disability and has significant emotional and socioeconomic effects for patients, their families, and health-care providers. The strongest link between patient and the risk of stroke is age. The age-specific incidence of stroke rises steadily as people get older. Aim: To evaluate clinical spectrum and risk factors in young stroke patients and to study epidemiology and etiology of young stroke patients at a tertiary level hospital, Patna, Bihar.Methods and Materials: Detailed clinical history was taken. Patients were clinically evaluated Laboratory investigations parameters included CBC, RFT, LFT, APTT, PT, VDRL, Lipid profile, FBS, PPBS, HbA1C, viral marker. Autoimmune profile-ANA, APLA profile, vasculitis marker. CXR, ECG, 2D Echo, 24 hr holter. Neuromaging was carried out with the help of NCCT MRI MRA. Results: When there was analysis of prevalence of risk factors in the young stroke patients then the most prevalent risk factors were atherosclerotic changes. However there were other risk factors found in stroke patients like rheumatic heart disease, vasculopathies and connective tissue disorders like SLE. Mitochondrial disorders, genetic disorders, post tubercular infarcts, traumatic heart diseases, chronic and acute disorders of head and neck, risk factors related to postpartum. etc.
Downloads
References
Kissela BM, Khoury JC, Alwell K, et al. Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology 2012; 79: 1781–1787.
Singhal AB, Biller J, Elkind MS, et al. Recognition and management of stroke in young adults and adolescents. Neurology 2013; 81: 1089–1097.
Arntz RM, van Alebeek ME, Synhaeve NE, et al. The very long-term risk and predictors of recurrent ischaemic events after a stroke at a young age: The FUTURE study. Eur Stroke J 2016; 1: 337–345.
Maino A, Rosendaal FR, Algra A, et al. Hypercoagulability is a stronger risk factor for ischaemic stroke than for myocardial infarction: a systematic review. PloS One 2015; 10: e0133523.
Adams HP, Jr., Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35–41.
Maaijwee NA, Rutten-Jacobs LC, Schaapsmeerders P, et al. Ischaemic stroke in young adults: risk factors and long-term consequences. Nat Rev Neurol 2014; 10: 315–325.
Mackay MT, Wiznitzer M, Benedict SL, et al. Arterial ischemic stroke risk factors: the International Pediatric Stroke Study. Ann Neurol 2011; 69: 130–140.
Kopyta I, Sarecka-Hujar B, Sordyl J, et al. The role of genetic risk factors in arterial ischemic stroke in pediatric and adult patients: a critical review. Mol Biol Rep 2014; 41: 4241–4251.
Rutten-Jacobs LC, Maaijwee NA, Arntz RM, et al. Risk factors and prognosis of young stroke. The FUTURE study: a prospective cohort study. Study rationale and protocol. BMC Neurol 2011; 11: 109.
Kamel H, Navi BB, Sriram N, et al. Risk of a thrombotic event after the 6-week postpartum period. New Engl J Med 2014; 370: 1307–1315.
Bousser MG, Amarenco P, Chamorro A, et al. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study. Cerebrovasc Dis 2009; 27: 509–518.
Rutten-Jacobs LC, Arntz RM, Maaijwee NA, et al. Long-term mortality after stroke among adults aged 18 to 50 years. JAMA 2013; 309: 1136–1144.
Widana, I.K., Sumetri, N.W., Sutapa, I.K., Suryasa, W. (2021). Anthropometric measures for better cardiovascular and musculoskeletal health. Computer Applications in Engineering Education, 29(3), 550–561. https://doi.org/10.1002/cae.22202
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
